Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

4.82B

Market cap4.82B

Price-Earnings ratio

108.76

Price-Earnings ratio108.76

Dividend yield

—

Dividend yield—

Average volume

2.26M

Average volume2.26M

High today

$77.62

High today$77.62

Low today

$75.17

Low today$75.17

Open price

$75.60

Open price$75.60

Volume

1.21M

Volume1.21M

52 Week high

$93.25

52 Week high$93.25

52 Week low

$33.31

52 Week low$33.31

PTGX News

Nasdaq 5d

Protagonist Therapeutics Reaches Analyst Target Price

In recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $71.54, changing hands...

Analyst ratings

93%

of 14 ratings

Buy

92.9%

Hold

7.1%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.